On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details

NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) Enters Agreement to Acquire Ownership Stake in The Physician’s Choice CBD LLC

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) this morning announced its entry into a funding agreement with The Physician’s Choice CBD LLC (“PCCBD”) of Phoenix, Arizona, which is dedicated to researching, developing and utilizing the highest quality of hemp-derived cannabidiol (“CBD”) in combination with well-studied and effective supplements to assist in supporting and regulating various … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) Enters Agreement to Acquire Ownership Stake in The Physician’s Choice CBD LLC”

NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Issues Shareholder Update on Washington Operations and California Cultivation Facility

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning provided an update to shareholders on its Washington state assets and Desert Hot Springs, California cultivation facility development. Per the update, Chemistree’s Washington state licensee partner has confirmed further advancements in crucial areas of its cultivation facility, including the appointment of key staff; upgrading of 288 on … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Issues Shareholder Update on Washington Operations and California Cultivation Facility”

NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Partners with NJ Medical Retail Cannabis License Applicant

Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) this morning announced that its wholly owned U.S. subsidiary, American CHM Investments Inc., has entered a letter of intent to partner with Applied Cannabis Sciences of New Jersey (“ACS”), a New Jersey-based medical retail dispensary applicant in the state’s upcoming round of request for applications, which is anticipated … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Partners with NJ Medical Retail Cannabis License Applicant”

NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Industry Expert as Chief Cannabis Officer

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning announced its appointment of Sheldon Aberman to the newly-created position of chief cannabis officer. According to the update, Aberman is one of the world’s foremost experts on commercial cannabis cultivation, with expertise, a hands-on approach and product development background as well as decades of experience managing and … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Industry Expert as Chief Cannabis Officer”

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements’ expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective … Continue reading “Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)”

NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Cannabis Industry Veteran with Passion, Deep Expertise to its Board

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) recently announced its appointment of Nicholas J. Zitelli to its board of directors. Zitelli is currently part-owner, director, and chief cannabis officer of Trans High Corporation (“THC”), the parent company for all HIGH TIMES brands, and is also the founder and CEO of the Cannabis Genetics Institute (“CGI”), a … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Cannabis Industry Veteran with Passion, Deep Expertise to its Board”

Contact us: 212.418.1217